跳至主要内容
临床试验/NCT01993745
NCT01993745已完成不适用

The Analysis of Heart Rate Variability With 24hrs Holter ECG and Serum Cardiac Fibrosis Markers in Critical Illness Patients Who Are With Cardiogenic Shock, With ECMO or IABP Support, or With APACH II Score >25)

National Taiwan University Hospital1 个研究点 分布在 1 个国家目标入组 106 人开始时间: 2008年5月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
106
试验地点
1
主要终点
Heart Rate Variability and serum cardiac fibrosis markers in critical illness patients

研究概览

简要总结

The study is to show the prognostic factor of HRV parameter and cardiac fibrosis markers in critical illness patients

详细描述

The analysis of Heart Rate Variability with 24hrs Holter ECG and serum cardiac fibrosis markers in critical illness patients who are with cardiogenic shock, with ECMO or IABP support, or with APACH II score >25)

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Cross Sectional

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • critical illness patients who are with cardiogenic shock, with ECMO or IABP support, or with APACH II score >25)

排除标准

  • pacemaker rhythm, not sign the permit

结局指标

主要结局

Heart Rate Variability and serum cardiac fibrosis markers in critical illness patients

时间窗: 2-4weeks

1. Outcome measurement: The measure is a composite outcome measure consisting of multiple measures (results to be reported as a single value for each Arm/Group), no changes are required 2. List the primary condition or disease being studied Shock needing ECMO support

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验